GSK-1070916

DB33589InvestigationalSmall molecule

GSK-1070916: Overview.

Mechanism: Pharmacologically active on Aurora kinase B and Aurora kinase C
Curator reviewed
Formula / weight: C₃₀H₃₃N₇O · 507.642 g/mol (avg)
Code names: GSK-1070916 · GSK-1070916A

Resolves to

Compound

Structure

InChIKeyQTBWCSQGBMPECM-UHFFFAOYSA-NSMILESCCN1C=C(C(=N1)C1=CC=C(NC(=O)N(C)C)C=C1)C1=C2C=C(NC2=NC=C1)C1=CC(CN(C)C)=CC=C1

Targets

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with GSK-1070916, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.